So far, the Obama administration has been undefeated in defending the accommodation process to the birth control benefit in the Affordable Care Act. How long will that streak last?
Reaching quantitative goals should not take priority over quality of care, voluntary use of contraception, and informed choice. The needs, desires, and well-being of women are paramount.
An amendment passed this week amid an 18-hour budget debate in the Texas House of Representatives could provide Texas’ reproductive health watchdogs with data they’ve long clamored for.
A new survey suggests that advocates have an opportunity to engage millennials in working toward unfettered access to reproductive health information and services.
A new Arkansas bill mentions abstinence explicitly while avoiding any direct mention of contraception—suggesting that state lawmakers are kidding themselves about the behavior of college students.
It’s been two years since the FDA made certain types of emergency contraception available without a prescription to women of all ages, but Indian Health Service has yet to update its policy.
An Arkansas lawmaker has introduced a bill that would create a “contraception incentive” for low-income women in the state’s Medicaid program, intending to offer a “breather to think about their life decisions that are affecting us as taxpayers.”
Liletta, an IUD just approved by the FDA, is being marketed in the United States through a unique partnership between manufacturers who hope to bring the device to more people at a lower cost. However, it is still unclear whether those savings will be felt by all women.
The U.S. Supreme Court on Monday granted a request by the University of Notre Dame, directing that a federal appeals court take another look at its decision to order the university to comply with the birth control benefit in the Affordable Care Act.
The 21st Century Women’s Health Act includes several provisions to both expand reproductive health-care access and improve research and public awareness on the topic.